Component
Human peptide/histidine transporter PHT1 / SLC15A4
Context-specific entity; species, compartment and exposure are stated on each claim.
4 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Human SLC15A4 interacted with TASL and was required for its endolysosomal localization and function in the tested cells.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Primary and transformed human immune cells; interaction mapping and mutagenesis.
- limitations
- Docking does not prove that the amount of histidine transported is the limiting signal.
- nutrient_topic
- L-Histidine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Histidine
- plain_language
- The transporter also serves as a docking location for a signaling adaptor.
- primary_references
- TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32433612/ · DOI 10.1038/s41586-020-2282-0
L-Histidine: supply, catabolism, histamine, receptors and cross-nutrient mechanisms (2026-09-19) · lines 378–384
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Primary and transformed human immune cells; interaction mapping and mutagenesis. · source_derived_draft · unverified_draft
## histidine-tasl-recruitment The transporter also serves as a docking location for a signaling adaptor. Human SLC15A4 interacted with TASL and was required for its endolysosomal localization and function in the tested cells. Model: Primary and transformed human immune cells; interaction mapping and mutagenesis. Limitations: Docking does not prove that the amount of histidine transported is the limiting signal. Evidence access: Primary full text TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32433612/ · DOI 10.1038/s41586-020-2282-0
Complete structured claim and evidence
Where it participates (unsigned role)
Artificially tethering TASL to endolysosomes restored TLR7-9-induced IRF5 activation and interferon/cytokine production in SLC15A4-deficient human cells.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Engineered human-cell localization/rescue experiments.
- limitations
- Shows transport is dispensable with this bypass; does not show native transport is irrelevant in every cell, or replicate mouse IRF7 experiments under identical conditions.
- nutrient_topic
- L-Histidine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Histidine
- plain_language
- A targeted scaffold bypass restored signaling without the transporter.
- primary_references
- SLC15A4 controls endolysosomal TLR7-9 responses by recruiting the innate immune adaptor TASL. · 2023 · https://pubmed.ncbi.nlm.nih.gov/37527038/ · DOI 10.1016/j.celrep.2023.112916
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Histidine: supply, catabolism, histamine, receptors and cross-nutrient mechanisms (2026-09-19) · lines 402–408
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Engineered human-cell localization/rescue experiments. · source_derived_draft · unverified_draft
## histidine-tasl-bypass A targeted scaffold bypass restored signaling without the transporter. Artificially tethering TASL to endolysosomes restored TLR7-9-induced IRF5 activation and interferon/cytokine production in SLC15A4-deficient human cells. Model: Engineered human-cell localization/rescue experiments. Limitations: Shows transport is dispensable with this bypass; does not show native transport is irrelevant in every cell, or replicate mouse IRF7 experiments under identical conditions. Evidence access: Primary abstract SLC15A4 controls endolysosomal TLR7-9 responses by recruiting the innate immune adaptor TASL. · 2023 · https://pubmed.ncbi.nlm.nih.gov/37527038/ · DOI 10.1016/j.celrep.2023.112916
Complete structured claim and evidenceThe conserved TASL pLxIS motif mediated recruitment and activation of IRF5 downstream of endolysosomal TLR7/8/9 stimulation.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human immune-cell mutagenesis and signaling experiments.
- limitations
- A shared transporter node does not establish a nutritional intervention.
- nutrient_topic
- L-Histidine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Histidine
- plain_language
- An adaptor connects the membrane-associated system to a transcription factor.
- primary_references
- TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32433612/ · DOI 10.1038/s41586-020-2282-0
L-Histidine: supply, catabolism, histamine, receptors and cross-nutrient mechanisms (2026-09-19) · lines 386–392
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human immune-cell mutagenesis and signaling experiments. · source_derived_draft · unverified_draft
## histidine-tasl-irf5 An adaptor connects the membrane-associated system to a transcription factor. The conserved TASL pLxIS motif mediated recruitment and activation of IRF5 downstream of endolysosomal TLR7/8/9 stimulation. Model: Human immune-cell mutagenesis and signaling experiments. Limitations: A shared transporter node does not establish a nutritional intervention. Evidence access: Primary full text TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32433612/ · DOI 10.1038/s41586-020-2282-0
Complete structured claim and evidenceDeleting TASL or SLC15A4 impaired the IRF response without abolishing the measured NF-kappaB or MAPK responses.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human immune-cell deletion experiments.
- limitations
- Does not imply all immune function is lost or a global histidine shortage.
- nutrient_topic
- L-Histidine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Histidine
- plain_language
- Loss of the system selectively disrupted one signaling branch.
- primary_references
- TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32433612/ · DOI 10.1038/s41586-020-2282-0
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Histidine: supply, catabolism, histamine, receptors and cross-nutrient mechanisms (2026-09-19) · lines 394–400
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human immune-cell deletion experiments. · source_derived_draft · unverified_draft
## histidine-tasl-loss-selectivity Loss of the system selectively disrupted one signaling branch. Deleting TASL or SLC15A4 impaired the IRF response without abolishing the measured NF-kappaB or MAPK responses. Model: Human immune-cell deletion experiments. Limitations: Does not imply all immune function is lost or a global histidine shortage. Evidence access: Primary full text TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32433612/ · DOI 10.1038/s41586-020-2282-0
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.